Sorted By:

Relevance


Burden on Patients: Two Steps Forward and One Step Back for HIV/AIDS Patients

PhRMA  |  Blog Post

” It has been a long road to finding successful treatments for suppressing and managing HIV/AIDS.
http://catalyst.phrma.org/burden-on-patients-two-steps-forward-and-one-step-back-for-hiv/aids-patients

Print Ad: Hospital Markups

PhRMA  |  Graphic

These hospital markups lead to higher costs for everyone - patients, employers and payers.
https://www.phrma.org/graphic/print-ad-hospital-markups

Director of Application Support and Business Intelligence – Information Technology

PhRMA  |  PhRMA Career

We are committed to the growth and development of our team members and offer many learning opportunities such as tuition reimbursement at both the undergraduate and graduate levels, industry on-site and off-site training, PhRMAcademy lunch and learn sessions, presentation skills, performance management and other management/professional develop programs.
https://www.phrma.org/careers/director-of-application-support-and-business-intelligence-information-technology

World AIDS Day: Making progress

PhRMA  |  Blog Post

The Centers for Disease Control and Prevention (CDC) estimates that over one million Americans over age 13 today currently have HIV.
http://catalyst.phrma.org/world-aids-day-2015

I'm Not Average: Matt May Have Cancer, but Cancer Doesn’t Have Him

PhRMA  |  Blog Post

Join the conversation about advances and innovations in cancer medicines using the hashtag #NotAverage.
http://catalyst.phrma.org/im-not-average-matt-may-have-cancer-but-cancer-doesnt-have-him

Cost of mental illness underscores need for new treatments

PhRMA  |  Blog Post

The new, targeted medicines in development span a variety of mental illnesses affecting adults and children, including: 40 for schizophrenia, which affects approximately 1 percent of U.S. adults; 29 for depression, including major depressive disorder, which affects 15.7 million U.S. adults and 2.8 million adolescents ages 12 to 17; 28 for substance abuse and addiction disorders, which affects the 25 million Americans ages 12 and older who have reported using an illicit drug in the past month; 14 for anxiety disorders, which affect 18 percent of U.S. adults and 25 percent of adolescents ages 13 to 18; and 10 for pediatric patients with mental illnesses, which affect one in five children ages 13 to 18.
http://catalyst.phrma.org/cost-of-mental-illness-underscores-need-for-new-treatments

ICYMI: Policy solutions for delivering innovative treatments to patients

PhRMA  |  Blog Post

In the coming weeks and months, we’ll be exploring these policy solutions further.
http://catalyst.phrma.org/icymi-policy-solutions-for-delivering-innovative-treatments-to-patients

Poll respondents appreciate economic benefits of innovation and call for more protections

PhRMA  |  Blog Post

It’s critical that policymakers and international leaders account for this and take steps to ensure innovation and innovative industries are supported and safeguarded from both domestic and international threats.
http://catalyst.phrma.org/poll-respondents-appreciate-economic-benefits-of-innovation-and-call-for-more-protections

PhRMA response to Washington Post and 60 Minutes stories

PhRMA  |  Blog Post

We will continue our efforts to fight this terrible epidemic, and we stand ready to work across the entire system to find ways to work together to do so.
http://catalyst.phrma.org/phrma-response-to-washington-post-and-60-minutes-stories

Foreign government pricing setting by any name harms innovation and access to medicines

PhRMA  |  Blog Post

These financial penalties have nothing to do with a product’s value, and serve to disadvantage U.S. manufacturers.
http://catalyst.phrma.org/foreign-gov-pricing-setting-by-any-name-harms-innovation-and-access-to-medicines

Case Study: How one online pharmacy knowingly endangered U.S. consumers

PhRMA  |  Blog Post

There are a number of ways medicines from overseas can be corrupted, and the increasing sophistication of counterfeiters and overseas drug sellers makes it hard to detect counterfeit or adulterated medicines – even for experts.
http://catalyst.phrma.org/case-study-how-one-online-pharmacy-knowingly-endangered-u.s.-consumers

Senior Director – Advocacy and Strategic Alliances

PhRMA  |  PhRMA Career

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org/careers/senior-director-advocacy-and-strategic-alliances

Patient Assistance Programs for HIV Get Boost from HHS Secretary Sebelius

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/patient-assistance-programs-for-hiv-get-boost-from-hhs-secretary-sebelius

HIV Aids In this Together

PhRMA  |  Report

This week, at the 2014 Research and Hope Awards, we are coming together to recognize those who have helped lead the fight against HIV/AIDS.
https://www.phrma.org/report/hiv-aids-in-this-together

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

PhRMA  |  Blog Post

Furthermore, the CBO reports that Medicaid-style rebates in Part D could stifle innovation for breakthrough treatments for conditions like Parkinson’s, arthritis and osteoporosis that disproportionately impact the elderly.
http://catalyst.phrma.org/medicare-monday-same-bad-ideas-continue-to-threaten-part-d-and-beneficiary-access-to-medicines

Medicare Monday: A discussion on affordability and access to medicines

PhRMA  |  Blog Post

All American patients and their caregivers deserve this commitment.”
http://catalyst.phrma.org/medicare-monday-a-discussion-on-affordability-and-access-to-medicines

BIO/PhRMA Principles on Responsible Sharing of Truthful and Non-Misleading Information about Medicines with Health Care Professionals and Payers

PhRMA  |  Codes & Guidelines

The Principles pertain primarily to data and information outside of FDA-approved labeling, and are intended to establish responsible, science-based parameters for accurate and trusted information sharing.
https://www.phrma.org/codes-and-guidelines/bio/phrma-principles-on-responsible-sharing-of-truthful-and-non-misleading-information-about-medicines-with-health-care-professionals-and-payers

Prescription Medicines: Costs in Context

PhRMA  |  From PhRMA

Today, thanks in part to innovative medicines, the U.S. death rate for HIV/AIDS has fallen nearly 88 percent since the 1990s, and is now considered by many to be a manageable chronic disease.
https://www.phrma.org/advocacy/cost-and-value

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

PhRMA  |  Blog Post

As the Congressional Budget Office and others have repeatedly indicated, direct government negotiation in Part D would not produce any savings in Medicare unless restrictions were placed on beneficiary access to needed medicines.
http://catalyst.phrma.org/medicare-monday-how-government-price-setting-in-part-d-could-reduce-innovation-shorten-life-expectancy-for-beneficiaries

Director– Policy and Research

PhRMA  |  PhRMA Career

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org

PhRMA Statement on Dr. Scott Gottlieb’s Nomination to Lead the U.S. Food and Drug Administration

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/phrma-statement-on-dr-scott-gottlieb-s-nomination-to-lead-the-u-s-food-and-drug-administration

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

PhRMA  |  Blog Post

How It Works Moderator: Drew Armstrong, health care reporter, Bloomberg Panelists: Joaquin Duato, executive vice president and chairman, pharmaceuticals, Johnson & Johnson Harold L.
http://catalyst.phrma.org/janssen-pfizer-walgreens-and-other-ceos-discuss-value-in-the-future-of-health-care

Amgen Chairman and CEO Robert A. Bradway Elected PhRMA Board Chairman-Elect

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org

Senior Director of Infrastructure and Operations

PhRMA  |  PhRMA Career

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org

New report provides recommendations for securing and protecting IP

PhRMA  |  Blog Post

Learn more about how PhRMA advocates for a modern IP system here.
http://catalyst.phrma.org/new-report-provides-recommendations-for-securing-and-protecting-ip

You have reviewed the first 100 results out of 2649. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next